Mitotic arrest induced by XK469, a novel antitumor agent, is correlated with the inhibition of cyclin B1 ubiquitination

International Journal of Cancer

Volumn 97, Issue 1, 2002, Pages 121-128

  Siskind, Victor ^a   Aitken, Joanne ^b   Green, Adèle ^a   Martin, Nicholas ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b CANCER COUNCIL QUEENSLAND   (Australia)

Author keywords

Antitumor; Cyclin B1; Ubiquitination; XK469

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; CASPASE; COLCHICINE; CYCLIN A; CYCLIN B1; CYCLIN E; DNA TOPOISOMERASE INHIBITOR; PROTEASOME; PROTEIN P53; UBIQUITIN; UNCLASSIFIED DRUG; XK 469;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; COLON TUMOR; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; SURVIVAL;

AMSACRINE; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL CYCLE; CELL DIVISION; COLONIC NEOPLASMS; CYCLIN B; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; MITOSIS; MITOTIC SPINDLE APPARATUS; PEPTIDE HYDROLASES; QUINOXALINES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN;

EID: 0036131856     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1570     Document Type: Article

References (34)

1. Preclinical antitumor efficacy of analogs of XK469: Sodium-(2-[4-(7- chloro-2-quinoxalinyloxy)phenoxy]propionate
2. Preclinical antitumor activity of XK469 (NSC 656889)
3. XK469, a selective topoisomerase IIbeta poison
4. Mechanism of antitumor action of a novel quinoxaline, XK469
5. Cdc2 regulatory factors
6. The cyclin-dependent protein kinases and the control of cell division
7. A new twist to the cell cycle
8. How proteolysis drives the cell cycle
9. Cyclin is degraded by the ubiquitin pathway
10. Roles of ubiquitin-mediated proteolysis in cell cycle control
11. Mechanisms and regulation of ubiquitin-mediated cyclin degradation
12. Mechanisms and regulation of the degradation of cyclin B
13. Role of Suc1 in the activation of the cyclosome by protein kinase Cdk1/cyclin B
14. Cyclin B2 undergoes cell cycle-dependent nuclear translocation and, when expressed as a non-destructible mutant, causes mitotic arrest in HeLa cells
15. The ubiquitin-mediated proteolytic pathway as a therapeutic area
16. Cellular uptake of a novel cytotoxic agent, cryptophycin-52, by human THP-1 leukemia cells and H-125 lung tumor cells
17. Mechanism of increased sensitivity to etoposide in a mitomycin C-resistant human bladder cancer cell line
18. Resistance of bone marrow-derived macrophages to apoptosis is associated with the expression of X-linked inhibitor of apoptosis protein in primary cultures of bone marrow cells
19. Induction of macrophage colony-stimulating factor receptor up-regulation in THP-1 human leukemia cells is dependent on the activation of c-fyn protein tyrosine kinase
20. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
21. Human THP-1 monocytic leukemic cells induced to undergo monocytic differentiation by bryostatin 1 are refractory to proteasome inhibitor-induced apoptosis
22. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells
23. The action of the DNA intercalating agents 4′-(9-acridinylamino) methanesulphon-m-anisidide and 1,4-bis(butylamino) benzo[g]phthalazine in U-937 human promonocytic cells: Relationship between cell cycle and differentiation
24. Effects of a new amsacrine derivative, N-5-dimethyl-9-(2-methoxy-4-methylsulfonylamino) phenylamino-4-acridine carbox-amide, on cultured mammalian cells
25. Apoptosis of S-phase HL-60 cells induced by DNA topoisomerase inhibitors: Detection of DNA strand breaks by flow cytometry using the in situ nick translation assay
26. Increased cyclin E level in retinoblastoma cells during programmed cell death
27. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway
28. Tubulin bound to colchicine forms polymers different from microtubules
29. P-glycoprotein, multidrug resistance and tumor progression
30. Ubiquitin-dependent protein degradation
31. Cell cycle regulation by the ubiquitin pathway
32. Targeting of substrates to the 26S proteasome
33. Regulation of the cyclin B degradation system by an inhibitor of mitotic proteolysis
34. DNA damage induces p21 protein expression by inhibiting ubiquitination in ML-1 cells